Clinical Trial Update: A Phase II/III Trial Comparing Transarterial Tirapazamine Embolization (TATE) With cTACE for Intermediate-stage Liver Cancer. [Phase 2, Phase 3]

View source ↗

Summary

A Phase II/III clinical trial is evaluating Transarterial Tirapazamine Embolization (TATE) versus conventional transarterial chemoembolization (cTACE) for inter…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Tirapazamine (tirapazamine)

Snippet

Sponsor: Zhejiang Raygene Pharmaceuticals Co., Ltd | Conditions: HCC | Phase 2, Phase 3 | Status: RECRUITING